These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36164436)

  • 1. Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach.
    Prabhu NB; Vinay CM; Satyamoorthy K; Rai PS
    3 Biotech; 2022 Nov; 12(11):287. PubMed ID: 36164436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conceptualization of functional single nucleotide polymorphisms of polycystic ovarian syndrome genes: an in silico approach.
    Prabhu BN; Kanchamreddy SH; Sharma AR; Bhat SK; Bhat PV; Kabekkodu SP; Satyamoorthy K; Rai PS
    J Endocrinol Invest; 2021 Aug; 44(8):1783-1793. PubMed ID: 33506367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update.
    Huang Z; Chavda VP; Vora LK; Gajjar N; Apostolopoulos V; Shah N; Chen ZS
    Front Pharmacol; 2022; 13():899633. PubMed ID: 35496298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNPs at 3'UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies.
    Safdar M; Khan MS; Karim AY; Omar SA; Smail SW; Saeed M; Zaheer S; Ali M; Ahmad B; Tasleem M; Junejo Y
    Mamm Genome; 2021 Oct; 32(5):389-400. PubMed ID: 34089082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management.
    Verma A; Adhikary A; Woloschak G; Dwarakanath BS; Papineni RVL
    Int J Radiat Biol; 2020 Nov; 96(11):1323-1328. PubMed ID: 32910699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing.
    Kumar SU; Priya NM; Nithya SR; Kannan P; Jain N; Kumar DT; Magesh R; Younes S; Zayed H; Doss CGP
    3 Biotech; 2021 Apr; 11(4):198. PubMed ID: 33816047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.
    Dinka H; Milkesa A
    Infect Genet Evol; 2020 Oct; 84():104386. PubMed ID: 32473977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses.
    Pająk B; Zieliński R; Manning JT; Matejin S; Paessler S; Fokt I; Emmett MR; Priebe W
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
    Choudhary S; Malik YS; Tomar S
    Front Immunol; 2020; 11():1664. PubMed ID: 32754161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease.
    Cafiero C; Re A; Micera A; Palmirotta R; Monaco D; Romano F; Fabrizio C; Di Francia R; Cacciamani A; Surico PL; D'Amato G; Pisconti S
    Pharmgenomics Pers Med; 2020; 13():463-484. PubMed ID: 33116761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First comprehensive computational analysis of functional consequences of
    Paniri A; Hosseini MM; Akhavan-Niaki H
    J Biomol Struct Dyn; 2021 Jul; 39(10):3576-3593. PubMed ID: 32410502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.
    Chen AT; Altschuler K; Zhan SH; Chan YA; Deverman BE
    Elife; 2021 Feb; 10():. PubMed ID: 33620031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Br B; Damle H; Ganju S; Damle L
    F1000Res; 2020; 9():663. PubMed ID: 32765844
    [No Abstract]   [Full Text] [Related]  

  • 17. In silico screening of the chicken genome for overlaps between genomic regions: microRNA genes, coding and non-coding transcriptional units, QTL, and genetic variations.
    Zorc M; Kunej T
    Chromosome Res; 2016 May; 24(2):225-30. PubMed ID: 26800695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
    Glinsky GV
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Deoxy-d-glucose exploits increased glucose metabolism in cancer and viral-infected cells: Relevance to its use in India against SARS-CoV-2.
    Mesri EA; Lampidis TJ
    IUBMB Life; 2021 Oct; 73(10):1198-1204. PubMed ID: 34418270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing FDA approved drugs as possible anti-SARS-CoV-2 medications using ligand-based computational approaches: sum of ranking difference-based model selection.
    De P; Kumar V; Kar S; Roy K; Leszczynski J
    Struct Chem; 2022; 33(5):1741-1753. PubMed ID: 35692512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.